2Chou AH, Liu CC, Chang CP, et ol. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates [Jl. PLoS One, 2012, 7 (4): e34834.
3Brunner D, FrankJ, Appl H, et ol. Serum-free cell culture: the serum-free media interactive online database [J]. ALTEX, 2010, 27 (1): 53-62.
4Kistner 0, Barrett PN, Mundt W, et al. Development of a mammalian cell (Vero ) derived candidate influenza virus vaccine [Jl. Vaccine, 1998, 16 (9-10): 960-968.
5Wu SC, Hsieh WC, Liau MY. Comparisons of microcarrier cell culture processes in one hundred mini-liter spinner flask and fifteen-liter bioreactor cultures [J]. Biopro Engi, 1998, 19 (6): 431-434.
6Van Der ValkJ, Brunner D, De Smet K, et ol. Optimization of chemically defined cell culture media-replacing fetal bovine serum in mammalian in vitro methods [J]. Toxicol In Vitro, 2010, 24 (4): 1053-1063.
7PietrzykJ J, WysockiJ, PejczJ, et al. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in com?parison to DTaP-IPV (Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3. 5, 5 and 16 months of age [J]. Vaccine, 2008, 26 (41): 5296-5303.
8Rourou S, Van Der Ark A, Van Der Velden T, et al. Deve?lopment of an animal-component free medium for vero cells culture [J]. Biotechnol Prog, 2009, 25 (6): 1752-1761.
9Rourou S, Van Der Ark A, Van Der Velden T, et al. A micro?carrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions [J]. Vaccine, 2007, 25 (19): 3879-3889.
10Chen A, Poh SL, Dietzsch C, et ol. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells [J]. BMC Biotechnol, 2011, 11 (1): 81-96.